The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)

Clinical trial NCT06699836 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06699836
Sponsor: CytoDyn, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (mCRC)

Start date: 2025-06-16
Primary completion: 2028-01-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.